Viemed Healthcare (NASDAQ:VMD) Stock Price Up 1.2% – Time to Buy?

Posted by Brian Himes on May 29th, 2026

Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) shares rose 1.2% on Thursday . The stock traded as high as $10.08 and last traded at $10.01. Approximately 228,480 shares traded hands during mid-day trading, a decline of 10% from the average daily volume of 254,562 shares. The stock had previously closed at $9.89.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 14th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Viemed Healthcare presently has an average rating of “Hold”.

View Our Latest Stock Report on Viemed Healthcare

Viemed Healthcare Trading Up 1.2%

The company has a market capitalization of $383.78 million, a price-to-earnings ratio of 27.05 and a beta of 1.15. The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06. The company’s 50 day simple moving average is $9.50 and its two-hundred day simple moving average is $8.29.

Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03). Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. The firm had revenue of $75.41 million during the quarter, compared to analyst estimates of $74.40 million. As a group, research analysts anticipate that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current fiscal year.

Insider Activity at Viemed Healthcare

In other news, President Michael Moore sold 65,000 shares of Viemed Healthcare stock in a transaction on Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the completion of the sale, the president directly owned 1,585,812 shares in the company, valued at approximately $13,907,571.24. The trade was a 3.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have sold 136,802 shares of company stock worth $1,237,976 in the last three months. Insiders own 20.00% of the company’s stock.

Institutional Investors Weigh In On Viemed Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Renaissance Technologies LLC lifted its stake in shares of Viemed Healthcare by 0.3% during the first quarter. Renaissance Technologies LLC now owns 442,200 shares of the company’s stock worth $4,073,000 after buying an additional 1,400 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Viemed Healthcare by 2.2% during the first quarter. Bank of New York Mellon Corp now owns 81,326 shares of the company’s stock worth $749,000 after buying an additional 1,773 shares during the period. Martingale Asset Management L P lifted its stake in shares of Viemed Healthcare by 6.0% during the fourth quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock worth $316,000 after buying an additional 2,399 shares during the period. Invesco Ltd. lifted its stake in shares of Viemed Healthcare by 17.1% during the fourth quarter. Invesco Ltd. now owns 21,773 shares of the company’s stock worth $162,000 after buying an additional 3,173 shares during the period. Finally, State of Alaska Department of Revenue purchased a new stake in shares of Viemed Healthcare in the 4th quarter valued at $25,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.